Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Geall

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Bioconjugate Chemistry|November 18, 2004
Targeting malaria with polyaminesAndrew J Geall, John A Baugh, Mark Loyevsky, et al.
Virology|May 26, 2015
Control of alphavirus-based gene expression using engineered riboswitchesChristie L Bell, Dong Yu, Christina D Smolke, et al.
Immunology|July 16, 2015
CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytesSandra Lazzaro, Cinzia Giovani, Simona Mangiavacchi, et al.
Plos One|August 16, 2016
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral ChallengeDiletta Magini, Cinzia Giovani, Simona Mangiavacchi, et al.
Communications Medicine|September 24, 2025
Durability of next-generation self-replicating RNA vaccine RBI-4000: a phase 1, randomized open label clinical trialChristian J Maine, Gaelle Picarda, Shigeki J Miyake-Stoner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 17, 2019
Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in MiceMarcelo M Samsa, Lesley C Dupuy, Clayton W Beard, et al.
Frontiers in Immunology|October 14, 2022
OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccinesRebekka Duhen, Michael Beymer, Shawn M Jensen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2017
Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine DesignTimothy Pepini, Anne-Marie Pulichino, Thomas Carsillo, et al.
Advances in Genetics|January 27, 2015
Self-amplifying mRNA vaccinesLuis A Brito, Sushma Kommareddy, Domenico Maione, et al.
Journal of Virology|October 16, 2015
Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus HemagglutininMichela Brazzoli, Diletta Magini, Alessandra Bonci, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Bioconjugate Chemistry|November 18, 2004
Targeting malaria with polyaminesAndrew J Geall, John A Baugh, Mark Loyevsky, et al.
Virology|May 26, 2015
Control of alphavirus-based gene expression using engineered riboswitchesChristie L Bell, Dong Yu, Christina D Smolke, et al.
Immunology|July 16, 2015
CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytesSandra Lazzaro, Cinzia Giovani, Simona Mangiavacchi, et al.
Plos One|August 16, 2016
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral ChallengeDiletta Magini, Cinzia Giovani, Simona Mangiavacchi, et al.
Communications Medicine|September 24, 2025
Durability of next-generation self-replicating RNA vaccine RBI-4000: a phase 1, randomized open label clinical trialChristian J Maine, Gaelle Picarda, Shigeki J Miyake-Stoner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 17, 2019
Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in MiceMarcelo M Samsa, Lesley C Dupuy, Clayton W Beard, et al.
Frontiers in Immunology|October 14, 2022
OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccinesRebekka Duhen, Michael Beymer, Shawn M Jensen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2017
Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine DesignTimothy Pepini, Anne-Marie Pulichino, Thomas Carsillo, et al.
Advances in Genetics|January 27, 2015
Self-amplifying mRNA vaccinesLuis A Brito, Sushma Kommareddy, Domenico Maione, et al.
Journal of Virology|October 16, 2015
Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus HemagglutininMichela Brazzoli, Diletta Magini, Alessandra Bonci, et al.
Pageof 3